Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease Potential for Targeting Inflammation With Canakinumab

被引：12
作者：
Cherney, David Z. I. [1 ,2 ]
Lytvyn, Yuliya [1 ,2 ]
McCullough, Peter A. [3 ]
机构：
[1] Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[3] Baylor Univ, Med Ctr, Baylor Heart & Vasc Hosp, Dallas, TX USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 21期
关键词：
canakinumab; cardiovascular risk; CKD; inflammation; C-REACTIVE PROTEIN; INTERLEUKIN-1-BETA INHIBITION;
D O I：
10.1016/j.jacc.2018.04.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2415 / 2418
页数：4
相关论文
共 50 条
  • [41] Inflammation and cachexia in chronic kidney disease
    Cheung, Wai W.
    Paik, Kyung Hoon
    Mak, Robert H.
    PEDIATRIC NEPHROLOGY, 2010, 25 (04) : 711 - 724
  • [42] Update on Inflammation in Chronic Kidney Disease
    Akchurin, Oleh M.
    Kaskel, Frederick
    BLOOD PURIFICATION, 2015, 39 (1-3) : 84 - 92
  • [43] Bone, inflammation and chronic kidney disease
    Mazzaferro, Sandro
    De Martini, Natalia
    Rotondi, Silverio
    Tartaglione, Lida
    Urena-Torres, Pablo
    Bover, Jordi
    Pasquali, Marzia
    CLINICA CHIMICA ACTA, 2020, 506 : 236 - 240
  • [44] Chronic kidney disease: the forgotten cardiovascular risk factor
    Barrios, V.
    Escobar, C.
    Echarri, R.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (06) : 964 - 965
  • [45] Proteomic cardiovascular risk assessment in chronic kidney disease
    Deo, Rajat
    Dubin, Ruth F.
    Ren, Yue
    Murthy, Ashwin C.
    Wang, Jianqiao
    Zheng, Haotian
    Zheng, Zihe
    Feldman, Harold
    Shou, Haochang
    Coresh, Josef
    Grams, Morgan
    Surapaneni, Aditya L.
    Bhat, Zeenat
    Cohen, Jordana B.
    Rahman, Mahboob
    He, Jiang
    Saraf, Santosh L.
    Go, Alan S.
    Kimmel, Paul L.
    Vasan, Ramachandran S.
    Segal, Mark R.
    Li, Hongzhe
    Ganz, Peter
    EUROPEAN HEART JOURNAL, 2023, 44 (23) : 2095 - +
  • [46] Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4
    Weber, Chek Ing Kiu
    Duchateau-Nguyen, Guillemette
    Solier, Corinne
    Schell-Steven, Annette
    Hermosilla, Ricardo
    Nogoceke, Everson
    Block, Geoffrey
    CLINICAL KIDNEY JOURNAL, 2014, 7 (02): : 167 - 173
  • [47] Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease
    Cachofeiro, Victoria
    Goicochea, Marian
    Garcia de Vinuesa, Soledad
    Oubina, Pilar
    Lahera, Vicente
    Luno, Jose
    KIDNEY INTERNATIONAL, 2008, 74 : S4 - S9
  • [48] A Machine Learning Analysis of Health Records of Patients With Chronic Kidney Disease at Risk of Cardiovascular Disease
    Chicco, Davide
    Lovejoy, Christopher A.
    Oneto, Luca
    IEEE ACCESS, 2021, 9 : 165132 - 165144
  • [49] Targeting inflammation: New therapeutic approaches in chronic kidney disease (CKD)
    Impellizzeri, Daniela
    Esposito, Emanuela
    Attley, James
    Cuzzocrea, Salvatore
    PHARMACOLOGICAL RESEARCH, 2014, 81 : 91 - 102
  • [50] Inflammation is associated with increased energy expenditure in patients with chronic kidney disease
    Utaka, S
    Avesani, CM
    Draibe, SA
    Kamimura, MA
    Andreoni, S
    Cuppari, L
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (04) : 801 - 805
12345